Andrew Sheely
Hoofd Techniek/Wetenschap/O&O bij VERVE THERAPEUTICS, INC.
Profiel
Andrew Sheely is currently the Vice President of Information Technology at Verve Therapeutics, Inc. Previously, he held positions as the Head of Information Technology at Dyax Corp., Kaleido Biosciences, Inc., and CRISPR Therapeutics, Inc. He completed his undergraduate degree at the University of Rhode Island and his graduate degree at Regis University.
Actieve functies van Andrew Sheely
| Bedrijven | Functie | Begin |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Andrew Sheely
| Bedrijven | Functie | Einde |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Hoofd Techniek/Wetenschap/O&O | - |
| DYAX CORP. | Hoofd Techniek/Wetenschap/O&O | - |
| KALEIDO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Andrew Sheely
| University of Rhode Island | Undergraduate Degree |
| Regis University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |